CAN
REGN icon

Cetera Advisor Networks’s Regeneron Pharmaceuticals REGN Stock Holding History

Cetera Advisor Networks’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.34M Sell
2,433
-3
-0.1% -$2.85K 0.01% 947
2023
Q4 		$2.14M Buy
2,436
+71
+3% +$58.5K 0.01% 929
2023
Q3 		$1.95M Sell
2,365
-37
-2% -$29.1K 0.01% 907
2023
Q2 		$1.73M Sell
2,402
-329
-12% -$254K 0.01% 928
2023
Q1 		$2.24M Buy
2,731
+280
+11% +$211K 0.02% 793
2022
Q4 		$1.77M Buy
2,451
+858
+54% +$633K 0.01% 852
2022
Q3 		$1.1M Sell
1,593
-665
-29% -$419K 0.01% 842
2022
Q2 		$1.33M Buy
2,258
+547
+32% +$356K 0.02% 754
2022
Q1 		$1.2M Sell
1,711
-270
-14% -$171K 0.01% 825
2021
Q4 		$1.25M Sell
1,981
-283
-13% -$174K 0.02% 802
2021
Q3 		$1.37M Buy
2,264
+332
+17% +$206K 0.02% 701
2021
Q2 		$1.08M Buy
1,932
+667
+53% +$338K 0.02% 799
2021
Q1 		$599K Sell
1,265
-529
-29% -$258K 0.01% 789
2020
Q4 		$867K Buy
1,794
+194
+12% +$105K 0.02% 587
2020
Q3 		$896K Buy
1,600
+129
+9% +$78.2K 0.02% 515
2020
Q2 		$917K Buy
1,471
+708
+93% +$402K 0.02% 494
2020
Q1 		$373K Buy
763
+188
+33% +$77.5K 0.01% 718
2019
Q4 		$217K Buy
+575
New +$193K 0.01% 1124
2017
Q3 		– Sell
-414
Closed -$203K – 938
2017
Q2 		$203K Buy
+414
New +$181K 0.01% 849
2016
Q4 		– Sell
-659
Closed -$265K – 984
2016
Q3 		$265K Buy
+659
New +$264K 0.01% 819
2016
Q1 		– Sell
-440
Closed -$238K – 851
2015
Q4 		$238K Buy
+440
New +$238K 0.02% 690
2015
Q3 		– Sell
-492
Closed -$225K – 879
2015
Q2 		$225K Hold
492
– – 0.01% 721
2015
Q1 		$225K Sell
492
-229
-32% -$97.1K 0.01% 725
2014
Q4 		$295K Hold
721
– – 0.02% 609
2014
Q3 		$261K Buy
+721
New +$242K 0.02% 657

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Cetera Advisor Networks's REGN Position: Q1 2024 in Review

Cetera Advisor Networks reduced its Regeneron Pharmaceuticals (REGN) stake by 0.12% in Q1 2024, selling an estimated $2.85K and leaving 2,433 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #947.

Cetera Advisor Networks first reported a position in REGN in Q3 2014 and has held it in 25 quarters since. 1,312 funds tracked by Wall St. Rank hold REGN as of Q1 2024.

  • Cetera Advisor Networks held 2,433 shares of Regeneron Pharmaceuticals worth $2.34M as of Q1 2024.
  • Cetera Advisor Networks sold 3 Regeneron Pharmaceuticals shares in Q1 2024, an estimated $2.85K.
  • Regeneron Pharmaceuticals made up 0.01% of Cetera Advisor Networks's portfolio in Q1 2024, its #947 holding.
  • Cetera Advisor Networks first reported a position in Regeneron Pharmaceuticals in Q3 2014 and has held it in 25 quarters since.
  • 1,312 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.